Open Label Study to Evaluate the Safety of Copaxone and to Monitor the Neurologic Course of Disease in Multiple Sclerosis Patients Treated with Copaxone

The PI of this project was: Christopher Luzzio, MD

This project was funded by: TEVA Pharmaceuticals

The term of this project was: July 2012 to January 2013

The number of subjects scanned during this project was: 5